1)Ebrahimiadib N, Modjtahedi BS, Roohipoor R et al:Succesful treatment strategies in granulomatosis with polyangiitis-associated peripheral ulcerative keratitis. Cornea 35:1459-1465, 2016
2)Tarabishy AB, Schulte M, Papaliodis GN et al:Wegener's granulomatosis:clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 55:429-444, 2010
3)Messmer EM, Foster CS:Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 43:379-396, 1999
4)Freidlin J, Wong IG, Acharya N:Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis. Br J Ophthalmol 91:1414, 2007
5)Pakrou N, Selva D, Leibovitch I:Wegener's granulomatosis:ophthlmic manifeatations and management. Semin Arthritis Rheum 35:284-292, 2006
6)Masaru M, Hiroshi T, Kyoko O:Anti-neutrophil cytoplasmic antibody-associated ocular manifestations in Japan:a review of 18 patients. Ocul Immunol Inflamm 20:1-6, 2020
7)Wertheim MS, Ross AH, Tole DM:The use of Campath in severe peripheral ulcerative keratitis associated with Wegener's granulomatosis. Eye(Lond)20:1453-1454, 2006
8)Ursea R, Castro DD, Bowen TJ et al:The role of conjunctival biopsy in the diagnosis of granulomatosis with polyangiitis. J Ophthalmic Inflamm Infect 5:1, 2015
9)Lu C-W, Zhou D-D, Wang J-L et al:Surgical treatment of peripheral ulcerative keratitis and necrotizing scleritis in granulomatosis with polyangiitis. Saudi Med J 37:205-207, 2016
10)Reddy SC, Tajunisah I, Rohana T:Bilateral scleromalacia perforans and peripheral cornea thinning in Wegener's granulomatosis. Int J Ophthalmol 4:439-442, 2011
11)Okumura K:Biomarkers in rheumatoid arthritis management. Clin Rheumatol Rel Res 32:68-74, 2020
12)Ramin S, Davood Y, Samira S:Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus. Jpn J Ophthalmol 61:218-222, 2017